General Information of Drug (ID: DMQU7HQ)

Drug Name
VTX-801 Drug Info
Indication
Disease Entry ICD 11 Status REF
Wilson disease 5C64.00 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMQU7HQ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
UX701 DMD1T2D Wilson disease 5C64.00 Phase 1/2 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Copper-transporting ATPase 2 (ATP7B) TTOPO51 ATP7B_HUMAN Not Available [1]

References

1 ClinicalTrials.gov (NCT04537377) A Phase I/II, Multicenter, Non-randomized, Open Label, Adaptive Design, 5-year Follow-up, Single Dose-escalation Study of VTX-801 in Adult Patients With Wilson's Disease. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Ultragenyx